“Our son had zero risk factors, was born completely healthy and at term (38.5 weeks, 7.5lbs). The fact he got so sick and so fast is a mystery. That’s what RSV can do in infants, even those born completely healthy.”
– A mother sharing her experience when her one-month-old son contracted RSV disease
Infants younger than six months of age are one of the groups most likely to experience severe RSV infection, and severe RSV infection in infants can result in hospitalization or intensive care unit (ICU) admission.17
RSV is the leading cause of bronchiolitis (inflammation of the small airways of the lungs) and pneumonia (a lung infection) in infants.17
Parents who have experienced an infant with RSV recount the trauma of seeing their small child appear limp and struggling to take a breath.18
One mother recounts crumpling to the floor when a team of doctors told her that her son’s health was deteriorating and he might need to be intubated.18
Wash your hands frequently – it is easy to come into contact with the virus on a surface then transfer it on your hands.
Avoid exposure – limit your baby’s contact with people who have fevers or colds.
Keep things clean – counters, doorknobs, and toys are all easy places to pick up the virus if someone in your home is sick.
Don’t smoke – babies exposed to tobacco smoke have a higher risk of getting RSV and may have more severe symptoms.
Talk to your healthcare provider – understand the protective pharmaceutical options available to you and together, with your healthcare provider, make an informed, shared decision regarding the best option for you and your baby.
There are two new protective pharmaceutical options approved by Health Canada to protect newborns from RSV:
A maternal RSV vaccine, named AbrysvoTM (Pfizer), which can be administered to pregnant people between 32 and 36 weeks gestation.
A monoclonal antibody, named BeyfortusTM (Sanofi), which can be administered to newborns at birth if born during RSV season or children up to 24 months of age who remain vulnerable to severe RSV disease through their second RSV season.
Wash your hands frequently – it is easy to come into contact with the virus on a surface then transfer it on your hands.
Avoid exposure – limit your baby’s contact with people who have fevers or colds.
Keep things clean – counters, doorknobs, and toys are all easy places to pick up the virus if someone in your home is sick.
Don’t smoke – babies exposed to tobacco smoke have a higher risk of getting RSV and may have more severe symptoms.
Talk to your healthcare provider – understand the protective pharmaceutical options available to you and together, with your healthcare provider, make an informed, shared decision regarding the best option for you and your baby.
There are two new protective pharmaceutical options approved by Health Canada to protect newborns from RSV:
A maternal RSV vaccine, named AbrysvoTM (Pfizer), which can be administered to pregnant people between 32 and 36 weeks gestation.
– FMWC Maternal RSV Task Force Member
– FMWC Maternal RSV Task Force Member
Protecting newborns from first breath.
Made possible through the financial support of Pfizer Canada. The opinions expressed are those of its authors and do not necessarily reflect the views and opinions of Pfizer Canada.
Protecting newborns from first breath.
Copyright © 2024 FMWC, All Rights Reserved.
Made possible through the financial support of Pfizer Canada. The opinions expressed are those of its authors and do not necessarily reflect the views and opinions of Pfizer Canada.